Neurology
Vimgreen Pharmaceuticals Completes Enrollment for Phase 2 Trial of Novel A2A Receptor Antagonist in Parkinson's Disease
Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling, announced the completion of enrollment ...
August 16, 2024 | News
UAE Approves LEQEMBI® for Early Alzheimer’s Treatment, Marking a Milestone in Regional Healthcare
Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-so...
August 14, 2024 | News
Genova Diagnostics Launches Innovative Non-Invasive Alzheimer's Blood Test in Strategic Partnership with Neurocode
Genova Diagnostics, a global leader in clinical laboratory services, proudly announces the launch of its groundbreaking Alzheimer's Assessment, a non...
August 12, 2024 | News
Sanyou Bio and JiAnTeBo Forge Strategic Partnership to Innovate Metabolic Disease Therapies
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Guangdong JiAnTeBo Biotechnology Co., Ltd. (hereinafter r...
August 08, 2024 | News
Eisai and EcoNaviSta Join Forces to Develop Dementia Ecosystem in Japan’s Super-Aging Society
Eisai Co., Ltd. and EcoNaviSta Inc. announced that they have entered into a business alliance agreement and commenced collaboration with the aim of buildin...
July 25, 2024 | News
CUHK Faculty of Medicine Identifies Gut Microbial Markers for Autism Diagnosis
The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among 1,627 children with and w...
July 12, 2024 | News
FDA Approves Donanemab for Early Alzheimer's: C2N Diagnostics' Biomarkers Play Crucial Role in Landmark Study
C2N Diagnostics, a leader in advanced brain health diagnostics, is closely tracking today’s decision by the U.S. Food and Drug Administration to appr...
July 03, 2024 | News
FDA Approves iRegene's NouvNeu001, Marking Milestone in Parkinson's Disease Treatment
U.S. Food and Drug Administration (FDA) approved the IND application for NouvNeu001, a cell therapy product from iRegene therapeutics targeting Parkinson's...
June 25, 2024 | News
Merck’s SMCxPRO® Immunoassay Technology Advances Parkinson’s Disease Research Through MJFF Collaboration
SMC® immunoassay technology from Merck detects small changes in biomarker levels, indicating level of cell dysfunction New understanding of cel...
June 24, 2024 | News
MLB Receives FDA Approval for TML-6 IND Application to Treat Alzheimer's Disease
MLB (Merry Life Biomedical Company, Ltd., Taiwan ) a biomedical company, announced that the U.S. Food and Drug Administration (FDA) h...
June 07, 2024 | News
Luye Pharma and Towa Pharmaceutical File NDA in Japan for Rivastigmine Twice Weekly Patch for Alzheimer’s
Luye Pharma Group announced that its partner Towa Pharmaceutical Co., Ltd. (Towa) has filed a New Drug Application (NDA) to the Ministry of Health, Labour ...
June 07, 2024 | News
NeuShen Therapeutics Begins Phase I Trial of NS-136, a Potential Breakthrough in Schizophrenia Treatment
NeuShen Therapeutics , a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today a...
May 10, 2024 | News
Eisai Launches Injectable Fycompa in Japan for Epilepsy Treatment
Eisai Co., Ltd. announcedthat the injection formulation of its in-house discovered antiepileptic drug (AED) Fycompa (perampanel hydrate) for intravenous (I...
April 19, 2024 | News
Actinogen Medical Launches Phase 2b XanaMIA Trial for Alzheimer's, Marks First Patient Treatment
Actinogen Medical Limited (ASX: ACW) announces that the first patient has been randomized and treated in the XanaMIA phase 2b clin...
April 16, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
